CF PHARMTECH(02652),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

02652 CF PHARMTECH

Market Closed 09-25 16:08:14

9.490

+0.115

+1.23%

High9.550	Low9.070	Vol250.80K
Open9.375	D1 Closing9.375	Amplitude5.12%
Mkt Cap4.10B	Tradable Cap3.07B	Total Shares432.00M
T/O2.35M	T/O Rate0.08%	Tradable Shares323.00M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.

{"stockData":{"symbol":"02652","market":"HK","secType":"STK","nameCN":"CF PHARMTECH","latestPrice":9.49,"timestamp":1790323694007,"preClose":9.375,"halted":0,"volume":250800,"delay":0,"changeRate":0.01226666666666669,"floatShares":323000000,"shares":432000000,"eps":0.0066,"marketStatus":"Market Closed","change":0.115,"latestTime":"09-25 16:08:14","open":9.375,"high":9.55,"low":9.07,"amount":2353698,"amplitude":0.0512,"askPrice":9.49,"askSize":2000,"bidPrice":9.27,"bidSize":1600,"shortable":3,"etf":0,"ttmEps":-0.018,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1790559000000},"marketStatusCode":7,"adr":0,"listingDate":1759852800000,"exchange":"SEHK","adjPreClose":9.375,"openAndCloseTimeList":[[1790299800000,1790308800000],[1790312400000,1790323200000]],"volumeRatio":0.12229016119530044,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02652/tweets","defaultTab":"tweets","newsList":[{"id":"1197173820","title":"AI-Driven Innovation at the Source: Targeting a Globally Scarce Inhaled Anti-Inflammatory Pipeline, CF Pharmtech Doubles Down on Novel Mechanisms for Pulmonary Delivery","url":"https://stock-news.laohu8.com/highlight/detail?id=1197173820","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1197173820?lang=en_us&edition=fundamental","pubTime":"2026-09-23 09:36","pubTimestamp":1790127386,"startTime":"0","endTime":"0","summary":"CF Pharmtech (02652) recently announced a research collaboration agreement with a tech enterprise founded by a team of scientists with backgrounds in relevant disciplines from a leading domestic...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CHAT","02652","QTOC","VTHR","159945","BK1191","AGIX","AIPO","ARTY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669079118","title":"CF PharmTech Doses First Subject in Phase I Trial for Inhaled Lung Disease Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2669079118","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669079118?lang=en_us&edition=fundamental","pubTime":"2026-09-22 12:17","pubTimestamp":1790050678,"startTime":"0","endTime":"0","summary":"CF PharmTech  has enrolled and dosed the first healthy subject in the Phase I clinical trial of ICF004, an inhaled drug being developed to treat interstitial lung disease.The Phase I trial will assess the safety, tolerability and pharmacokinetics of single and multiple doses in healthy subjects in China, according to a Monday Hong Kong bourse filing.ICF004 is designed to deliver the drug directly to the lungs to increase local exposure while reducing systemic exposure.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1191","02652"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1175867609","title":"CF PharmTech completes first healthy volunteer dosing in Phase I trial of inhaled ILD therapy ICF004","url":"https://stock-news.laohu8.com/highlight/detail?id=1175867609","media":"Bulletin Express","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1175867609?lang=en_us&edition=fundamental","pubTime":"2026-09-21 23:01","pubTimestamp":1790002905,"startTime":"0","endTime":"0","summary":"CF PharmTech announced the successful enrolment and dosing of the first healthy subject in its Phase I clinical trial evaluating ICF004, an inhalation powder developed for interstitial lung disease...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02652"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1104672753","title":"CF Pharmtech Surges Over 10% Intraday as ICF001 Targets Four Indications","url":"https://stock-news.laohu8.com/highlight/detail?id=1104672753","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1104672753?lang=en_us&edition=fundamental","pubTime":"2026-09-14 11:30","pubTimestamp":1789356623,"startTime":"0","endTime":"0","summary":"Shares of CF Pharmtech (02652) climbed sharply this morning, hitting an intraday peak with a gain exceeding 10%. As of the time of writing, the stock has pared gains to trade up 1.06% at HKD 10.47,...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02652","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1131192332","title":"Hong Kong Stock Alert: CF PHARMTECH Surges Over 10% in Morning Session as Clinical Approvals for ICF001 Pave the Way for Global Phase I Trials","url":"https://stock-news.laohu8.com/highlight/detail?id=1131192332","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1131192332?lang=en_us&edition=fundamental","pubTime":"2026-09-11 10:14","pubTimestamp":1789092852,"startTime":"0","endTime":"0","summary":"CF PHARMTECH (02652) shares jumped more than 10% early on Thursday before paring gains to trade 8.23% higher at HK$10.39, with turnover reaching HK$28.74 million. The price surge follows the...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VXUS","BK4585","BK4588","BK1191","02652","KCAI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1172001994","title":"CF Pharmtech (02652) Secures 2026 Technology Innovation Golden Bull Award, Pushing Boundaries in Inhalation Therapies to Shape the Future of Respiratory Care","url":"https://stock-news.laohu8.com/highlight/detail?id=1172001994","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1172001994?lang=en_us&edition=fundamental","pubTime":"2026-09-07 11:06","pubTimestamp":1788750387,"startTime":"0","endTime":"0","summary":"On September 6, 2026, the \"2026 Xiamen Sci-Tech Innovation and Securities Industry Development Conference暨Securities Industry Golden Bull Award Ceremony,\" hosted by China Securities Journal, took...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02652","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664631108","title":"CF PharmTech (SEHK:2652) Stock Pressured By Widening Losses And Thin Profit Clarity","url":"https://stock-news.laohu8.com/highlight/detail?id=2664631108","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664631108?lang=en_us&edition=fundamental","pubTime":"2026-09-01 23:32","pubTimestamp":1788276756,"startTime":"0","endTime":"0","summary":"CF PharmTech stock has already been under pressure, with the share price down about 31% over the past three months, and today’s earnings give investors a clear reason why. The market is reacting to a story that is not about revenue size; it is about profits that have slipped into a loss again.\nThe headline for this half is simple. CF PharmTech generated revenue of C¥210.154 million but reported a net loss of C¥10.506 million and a loss per share. That profit squeeze lands on a stock already...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2652/cf-pharmtech-shares/news/cf-pharmtech-sehk2652-stock-pressured-by-widening-losses-and","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2652/cf-pharmtech-shares/news/cf-pharmtech-sehk2652-stock-pressured-by-widening-losses-and","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["02652","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1111083124","title":"CF Pharmtech Reports Interim Revenue of RMB 210 Million, Up 2.1% Year-on-Year","url":"https://stock-news.laohu8.com/highlight/detail?id=1111083124","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1111083124?lang=en_us&edition=fundamental","pubTime":"2026-08-31 22:07","pubTimestamp":1788185267,"startTime":"0","endTime":"0","summary":"CF Pharmtech (02652) has released its interim results for 2026, posting revenue of RMB 210 million, a 2.1% increase compared to the same period last year. This growth was primarily driven by...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","02652"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663165006","title":"CF PharmTech FY26 H1 Net Loss Widens to RMB 10.51 Million; Revenue Rises 2.08% to RMB 210.15 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2663165006","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663165006?lang=en_us&edition=fundamental","pubTime":"2026-08-31 21:36","pubTimestamp":1788183360,"startTime":"0","endTime":"0","summary":"CF PharmTech FY26 H1 net loss widens to RMB 10.51 million; revenue rises 2.08% to RMB 210.15 millionCF PharmTech posted a net loss of RMB 10.51 million, worsening from RMB 1.23 million a year earlier.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nNDL98lX14:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02652","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1190191183","title":"CF Pharmtech Wraps Up Issuance of 21.75 Million New H-Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=1190191183","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1190191183?lang=en_us&edition=fundamental","pubTime":"2026-08-28 23:46","pubTimestamp":1787931980,"startTime":"0","endTime":"0","summary":"CF Pharmtech (02652) has announced the completion of a share issuance, marking a significant step in its capital management strategy.According to the company's latest disclosure, on 6 August 2026, CF...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","02652"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1138766694","title":"CF PharmTech Releases Revised Articles of Association: Capital Structure, Governance Framework and Dividend Rules Clarified","url":"https://stock-news.laohu8.com/highlight/detail?id=1138766694","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1138766694?lang=en_us&edition=fundamental","pubTime":"2026-08-28 22:23","pubTimestamp":1787927004,"startTime":"0","endTime":"0","summary":"CF PharmTech (CF PharmTech, 02652) has published its updated Articles of Association, effective 6 August 2026, detailing the company’s capital structure, shareholder rights and corporate-governance...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02652"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662099896","title":"CF PharmTech Files HKEX Next-Day Disclosure Return, Lifts Share Capital with 21,747,700 New H Shares at HKD 13.82 Each","url":"https://stock-news.laohu8.com/highlight/detail?id=2662099896","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662099896?lang=en_us&edition=fundamental","pubTime":"2026-08-28 22:06","pubTimestamp":1787925970,"startTime":"0","endTime":"0","summary":"CF PharmTech files HKEX next-day disclosure return, lifts share capital with 21,747,700 new H shares at HKD 13.82 eachCF Pharmtech filed a next day disclosure return covering an issuance of 21,747,700","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260828:nNDL9qNHrD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02652","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1195250789","title":"Hong Kong Stock Alert | CF PHARMTECH (02652) Surges Over 20% Intraday on Two New Clinical Approvals for ICF001, Highlighting Long-Acting Inhaled Prodrug Design Edge","url":"https://stock-news.laohu8.com/highlight/detail?id=1195250789","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1195250789?lang=en_us&edition=fundamental","pubTime":"2026-08-27 10:14","pubTimestamp":1787796855,"startTime":"0","endTime":"0","summary":"CF PHARMTECH (02652) shares climbed more than 20% during intraday trading, last up 6.14% at HK$16.2 with turnover reaching HK$58.31 million.The company recently announced that its self-developed...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","KCAI","BK1191","BK4588","02652","VXUS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1132112506","title":"Hong Kong Stock Movers | CF PHARMTECH (02652) Surges Over 5% as ICF001 Covers Four Major Indications Including IPF and PPF, with Plans to Launch Phase I Trials Domestically and Overseas","url":"https://stock-news.laohu8.com/highlight/detail?id=1132112506","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1132112506?lang=en_us&edition=fundamental","pubTime":"2026-08-25 09:51","pubTimestamp":1787622692,"startTime":"0","endTime":"0","summary":"Shares of CF PHARMTECH (02652) climbed more than 5% in Hong Kong trading, last up 5.46% at HK$16.06 with turnover reaching HK$6.502 million. The company announced that its self-developed long-acting...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KCAI","02652","VXUS","BK4585","BK4588","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1104287705","title":"CF PHARMTECH Secures Two Additional Clinical Approvals for ICF001, Expanding Coverage Across Four Major Indications","url":"https://stock-news.laohu8.com/highlight/detail?id=1104287705","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1104287705?lang=en_us&edition=fundamental","pubTime":"2026-08-24 21:00","pubTimestamp":1787576431,"startTime":"0","endTime":"0","summary":"CF PHARMTECH (02652) has announced that its self-developed long-acting inhaled dry powder candidate drug, ICF001, has received implied approval from the National Medical Products Administration to...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","02652"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1144024774","title":"CF PHARMTECH (02652) Secures Expanded Clinical Trial Approval for ICF001 Across Additional Indications","url":"https://stock-news.laohu8.com/highlight/detail?id=1144024774","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1144024774?lang=en_us&edition=fundamental","pubTime":"2026-08-24 19:41","pubTimestamp":1787571660,"startTime":"0","endTime":"0","summary":"CF PHARMTECH (02652) has announced that its independently developed long-acting inhaled dry powder candidate drug, ICF001, has received implied clinical trial approval from the National Medical...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BMED","MDTX","IBBQ","02652","PSYK","IBBJ","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661579275","title":"CF Pharmtech, - Receives Nmpa Implied Clinical Trial Approvals for Icf001 in Ipf and Ppf","url":"https://stock-news.laohu8.com/highlight/detail?id=2661579275","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661579275?lang=en_us&edition=fundamental","pubTime":"2026-08-24 19:36","pubTimestamp":1787571383,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nFWN44L068:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1191","02652"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661275570","title":"CF PharmTech Says NMPA Clears Icf001 Trials in IPF, PPF","url":"https://stock-news.laohu8.com/highlight/detail?id=2661275570","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661275570?lang=en_us&edition=fundamental","pubTime":"2026-08-24 19:36","pubTimestamp":1787571383,"startTime":"0","endTime":"0","summary":"CF PharmTech says NMPA clears ICF001 trials in IPF, PPFCF PharmTech received NMPA implied clinical trial clearances for ICF001 in idiopathic pulmonary fibrosis, plus progressive pulmonary fibrosis.The","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nNDL13HdT2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","02652"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1162951635","title":"CF PharmTech Sets 31 August 2026 Board Meeting to Review H1 2026 Results and Potential Interim Dividend","url":"https://stock-news.laohu8.com/highlight/detail?id=1162951635","media":"Bulletin Express","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1162951635?lang=en_us&edition=fundamental","pubTime":"2026-08-19 16:49","pubTimestamp":1787129352,"startTime":"0","endTime":"0","summary":"CF PharmTech, Inc. has announced that its board of directors will convene on 31 August 2026 to deliberate several key agenda items, chief among them the approval and publication of the unaudited...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02652"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660244514","title":"CF PharmTech Schedules Board Meeting to Review Interim Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2660244514","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660244514?lang=en_us&edition=fundamental","pubTime":"2026-08-19 16:41","pubTimestamp":1787128864,"startTime":"0","endTime":"0","summary":"CF PharmTech schedules board meeting to review interim resultsCF PharmTech will hold a board meeting on Aug. 31, 2026 to review unaudited interim results for the six months ended June 30, 2026.The boa","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260819:nNDL9GD66C:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02652","BK1191"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.cfpharmtech.com","stockEarnings":[{"period":"1week","weight":-0.1373},{"period":"1month","weight":-0.3801},{"period":"3month","weight":-0.4873},{"period":"6month","weight":-0.5845},{"period":"1year","weight":-0.3566},{"period":"ytd","weight":-0.7289}],"compareEarnings":[{"period":"1week","weight":-0.0097},{"period":"1month","weight":-0.0446},{"period":"3month","weight":0.0811},{"period":"6month","weight":-0.0177},{"period":"1year","weight":-0.0746},{"period":"ytd","weight":-0.0437}],"compareStock":{"symbol":"HSI","name":"HSI"},"description":"CF PharmTech, Inc. is a China-based company primarily the research and development, production and sale of respiratory drugs and other related medical products. The Company’s product portfolio primarily focused on respiratory diseases, including asthma, chronic obstructive pulmonary disease (COPD) and allergic rhinitis. The Company's primary products include CF017, a budesonide suspension for inhalation targeting bronchial asthma, and CF018, an azelastine hydrochloride and fluticasone propionate nasal spray approved for allergic rhinitis. The Company mainly conducts its business in the domestic market.","exchange":"SEHK","name":"CF PHARMTECH","nameEN":"CF PHARMTECH"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"CF PHARMTECH(02652),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest CF PHARMTECH(02652) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"CF PHARMTECH,02652,CF PHARMTECH股票,CF PHARMTECH股票老虎,CF PHARMTECH股票老虎国际,CF PHARMTECH行情,CF PHARMTECH股票行情,CF PHARMTECH股价,CF PHARMTECH股市,CF PHARMTECH股票价格,CF PHARMTECH股票交易,CF PHARMTECH股票购买,CF PHARMTECH股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"CF PHARMTECH(02652),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest CF PHARMTECH(02652) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}